日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients

建立与前列腺癌患者免疫功能障碍相关的新型铁死亡相关预后亚型

Dechao Feng, Zhouting Tuo, Jie Wang, Luxia Ye, Dengxiong Li, Ruicheng Wu, Wuran Wei, Yubo Yang, Chi Zhang

Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients

脯氨酰 4-羟化酶亚基 β (P4HB) 可作为前列腺癌患者的预后和放射敏感性生物标志物

Dechao Feng #, Li Li #, Dengxiong Li, Ruicheng Wu, Weizhen Zhu, Jie Wang, Luxia Ye, Ping Han

The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma

acsl1 的多组学分析揭示了其作为透明细胞肾细胞癌的肿瘤微环境和预后生物标志物的转化意义

Yang Yang #, Jiayu Liang #, Junjie Zhao #, Xinyuan Wang, Dechao Feng, Hang Xu, Yu Shen, Yaowen Zhang, Jindong Dai, Zhipeng Wang, Qiang Wei, Zhenhua Liu

Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis

揭示 CXCL12 在膀胱癌中的临床意义和肿瘤免疫状况:来自多组学分析的见解

Zhouting Tuo, Dechao Feng, Zhiwei Jiang, Liangkuan Bi, Chao Yang, Qi Wang

Programmed death-ligand 2 (PD-L2) expression in bladder cancer

膀胱癌中的程序性死亡配体 2 (PD-L2) 表达

Yubo Yang, Xiaoming Wang, Yunjin Bai, Dechao Feng, Ao Li, Yin Tang, Xin Wei, Ping Han

Targeted Inhibition of P4HB Promotes Cell Sensitivity to Gemcitabine in Urothelial Carcinoma of the Bladder

靶向抑制 P4HB 可增强膀胱尿路上皮癌细胞对吉西他滨的敏感性

Xiaoming Wang #, Yunjin Bai #, Facai Zhang, Yubo Yang, Dechao Feng, Ao Li, Zhiqiang Yang, Dengxiong Li, Yin Tang, Xin Wei, Wuran Wei, Ping Han